Filing Details
- Accession Number:
- 0001127602-21-010773
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-16 16:07:56
- Reporting Period:
- 2021-03-15
- Accepted Time:
- 2021-03-16 16:07:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1682852 | Moderna Inc. | MRNA | Biological Products, (No Disgnostic Substances) (2836) | 813467528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1690927 | Zvi Tal Zaks | C/O Moderna, Inc. 200 Technology Square Cambridge MA 02139 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-03-15 | 10,000 | $20.93 | 10,000 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-03-15 | 34 | $14.22 | 10,034 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-03-15 | 411 | $136.00 | 9,623 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-03-15 | 801 | $137.00 | 8,822 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-03-15 | 602 | $138.26 | 8,220 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-03-15 | 300 | $139.09 | 7,920 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-03-15 | 1,874 | $140.38 | 6,046 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-03-15 | 2,988 | $141.31 | 3,058 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-03-15 | 2,101 | $142.17 | 957 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-03-15 | 957 | $143.09 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-03-15 | 10,000 | $0.00 | 10,000 | $20.93 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-03-15 | 34 | $0.00 | 34 | $14.22 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 170,798 | 2029-03-08 | No | 4 | M | Direct | |
| 40,141 | 2028-02-28 | No | 4 | M | Direct |
Footnotes
- The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $135.47 to $136.41. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $136.61 to $137.43. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $137.71 to $138.61. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $138.78 to $139.36. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $139.81 to $140.80. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $140.82 to $141.77. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $141.85 to $142.78. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $142.87 to $143.58. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- 25% of this option vested and became exercisable on March 8, 2020 with the remainder vesting in 12 equal quarterly installments thereafter.
- 25% of this option vested and became exercisable on February 27, 2019 with the remainder vesting in 12 equal quarterly installments thereafter.
Billionaire Hedge Funds
